Loading...

FDA Approvals And Rising API Demand Will Drive Margin Expansion Over The Long Term

Published
16 Dec 25
Views
11
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-6.9%
7D
-2.3%

Author's Valuation

₹56618.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value